Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 7,601,087 | 7,601,087 | 0 | $354.97M | $605.43M | 58.53% | +$250.46M |
| Tyra Biosciences, Inc.(TYRA) | 4,055,861 | 4,055,861 | 0 | $56.74M | $106.63M | 10.31% | +$49.89M |
| Tango Therapeutics, Inc.(TNGX) | 5,533,980 | 7,266,081 | +1,732,101 | $46.49M | $64.38M | 6.22% | +$17.89M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 7,162,637 | 7,162,637 | 0 | $85.95M | $58.59M | 5.66% | -$27.36M |
| Relay Therapeutics, Inc.(RLAY) | 3,846,409 | 4,701,506 | +855,097 | $20.08M | $39.77M | 3.85% | +$19.70M |
| Zymeworks Inc.(ZYME) | 1,113,946 | 1,113,946 | 0 | $19.03M | $29.33M | 2.84% | +$10.30M |
| Alumis Inc | 2,915,998 | 2,915,998 | 0 | $11.63M | $28.46M | 2.75% | +$16.83M |
| Kymera Therapeutics, Inc.(KYMR) | 340,909 | 278,896 | -62,013 | $19.30M | $21.70M | 2.10% | +$2.41M |
| Engene Holdings Inc COM | 0 | 2,124,943 | +2,124,943 | $0 | $19.19M | 1.85% | +$19.19M |
| Mersana Therapeutics Inc | 482,689 | 482,689 | 0 | $3.75M | $13.96M | 1.35% | +$10.22M |
| Cullinan Therapeutics, Inc.(CGEM) | 1,141,145 | 1,141,145 | 0 | $6.77M | $11.81M | 1.14% | +$5.04M |
| Context Therapeutics Inc.(CNTX) | 7,419,355 | 7,419,355 | 0 | $7.19M | $10.91M | 1.05% | +$3.72M |
| ARS Pharmaceuticals, Inc.(SPRY) | 660,703 | 660,703 | 0 | $6.64M | $7.70M | 0.74% | +$1.06M |
| Arvinas, Inc.(ARVN) | 1,408,394 | 539,394 | -869,000 | $12.00M | $6.40M | 0.62% | -$5.60M |
| Silence Therapeutics plcADS(SLN) | 952,400 | 952,400 | 0 | $4.94M | $5.79M | 0.56% | +$847.6K |
| Monte Rosa Therapeutics, Inc.(GLUE) | 0 | 279,237 | +279,237 | $0 | $4.38M | 0.42% | +$4.38M |
| Boundless Bio, Inc.(BOLD) | 1,228,069 | 0 | -1,228,069 | $1.51M | $0 | — | -$1.51M |